The Foreign Investment Promotion Board (FIPB) has approved eleven proposals of foreign direct investment (FDI) amounting to Rs 1075.91 crore. The approvals include Solar Arise India projects involving FDI of Rs 216.01 crore, SeQuent Scientific, Mumbai involving FDI of upto Rs 400 crore and proposal of BLP Wind Assets Holding for an amount of Rs 371 crore for setting up a joint venture firm for making downstream investments in the renewable energy sector. Also, JP Morgan Asset Management (Asia) Inc USA has got approval for the acquisition of remaining 25 per cent held by JP Morgan India in the joint venture set up in 2006 by the two companies, entailing investment up to Rs 80.13 crore.
On the other hand the board sent two proposals relating to Aurobindo Pharma, Hyderabad and Glenmark Pharmaceuticals, Mumbai for consideration of Cabinet Committee on Economic Affairs (CCEA), headed by Prime Minister Narendra Modi, to raise the cap of foreign institutional investor (FII) holding to 49 per cent, from 35.07 per cent at present. The investment involved in each of the proposal is above Rs 1,200 crore.
FIPB rejected foreign investment application of Johnson and Johnson proposal seeking deletion of the standard pharma conditions, stipulated in the approved letter and proposal of Singapore-based AppDynamics Asia Pacific Pte for replacing of partners of the proposed LLP, as the existing have tendered their resignation.
Recently, the government has eased the procedures for companies seeking approval for foreign direct investment; they can now e-file a single copy application with the FIPB. The applicants would also get SMS/email alerts related to the queries raised by the administrative ministries, inclusion of the proposal in the scheduled FIPB meeting and decisions.
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: